# Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy

> **NCT02307825** · PHASE4 · COMPLETED · sponsor: **Centre hospitalier de l'Université de Montréal (CHUM)** · enrollment: 129 (actual)

## Conditions studied

- Chronic Rhinosinusitis
- High-risk Patient

## Interventions

- **DRUG:** Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02307825
- **Lead sponsor:** Centre hospitalier de l'Université de Montréal (CHUM)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2017-08-15
- **Final completion:** 2017-12-31
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2018-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02307825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02307825, "Azithromycin for Patients With Chronic Rhinosinusitis Failing Medical and Surgical Therapy". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02307825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*